Procollagen‐3  N ‐terminal peptide measurements for the detection of liver fibrosis in methotrexate‐treated patients with psoriasis: daily practice use and clinical implications

2017 ◽  
Vol 177 (5) ◽  
pp. 1454-1457 ◽  
Author(s):  
J.M.P.A. Reek ◽  
S.P. Menting ◽  
W.W.L. Janssen ◽  
R. Dhaliwal ◽  
A.C. Heijboer ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Daily Practice ◽  
Clinical Implications

Which are the best cut-off values for predicting different stages of liver fibrosis for 2D-SWE.GE in daily practice?

2017 ◽  
Vol 66 (1) ◽  
pp. S240 ◽  
Author(s):  
F. Bende ◽  
I. Sporea ◽  
A. Popescu ◽  
R. Sirli ◽  
M. Danila ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Daily Practice

scholarly journals Perceptions of Compensation Strategies for Gait Impairments in Parkinson’s Disease: A Survey Among 320 Healthcare Professionals

2020 ◽  
Vol 10 (4) ◽  
pp. 1775-1778
Author(s):  
Anouk Tosserams ◽  
Maarten J. Nijkrake ◽  
Ingrid H.W.M. Sturkenboom ◽  
Bastiaan R. Bloem ◽  
Jorik Nonnekes
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Clinical Practice ◽  
Online Survey ◽  
Healthcare Professionals ◽  
Daily Practice ◽  
Clinical Implications ◽  
Knowledge Gap ◽  
Gait Impairments ◽  
Specific Expertise

Compensation strategies are an essential part of managing gait impairments in people with Parkinson’s disease (PD). We conducted an online survey among 320 healthcare professionals with specific expertise in PD management, to evaluate their knowledge of compensation strategies for gait impairments in people with PD, and whether they applied these in daily practice. Only 35% of professionals was aware of all categories of compensation strategies. Importantly, just 23% actually applied all seven available categories of strategies when treating people with PD in clinical practice. We discuss the clinical implications, and provide recommendations to overcome this knowledge gap.

scholarly journals Cyst-related primary lung malignancies: an important and relatively unknown imaging appearance of (early) lung cancer

2018 ◽  
Vol 27 (150) ◽  
pp. 180079 ◽  
Author(s):  
Onno M. Mets ◽  
Cornelia M. Schaefer-Prokop ◽  
Pim A. de Jong
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Daily Practice ◽  
Common Finding ◽  
Clinical Implications ◽  
Delay In Diagnosis ◽  
Imaging Appearance ◽  
Lung Malignancies ◽  
Practice Literature ◽  
Tomography Appearance

It is well known that lung cancer can manifest itself in imaging as solid and subsolid nodules or masses. However, in this era of increased computed tomography use another morphological computed tomography appearance of lung cancer is increasingly being recognised, presenting as a malignancy in relation to cystic airspaces. Despite the fact that it seems to be a relatively common finding in daily practice, literature on this entity is scarce and presumably the overall awareness is limited. This can lead to misinterpretation and delay in diagnosis and, therefore, increased awareness is urgently needed. This review aims to illustrate the imaging appearances of cyst-related primary lung malignancies, demonstrate its mimickers and potential pitfalls, and discuss the clinical implications based on the available literature and our own experience in four different hospitals.

Hospital-Based Clinical Implications of the Novel Oral Anticoagulant, Dabigatran Etexilate, in Daily Practice

2011 ◽  
Vol 39 (3) ◽  
pp. 23-34 ◽  
Author(s):  
Ryan Wilcox ◽  
Robert C. Pendleton ◽  
Kristi J. Smock ◽  
George M. Rodgers
Keyword(s):  
Oral Anticoagulant ◽  
Dabigatran Etexilate ◽  
Daily Practice ◽  
Clinical Implications ◽  
The Novel ◽  
Novel Oral Anticoagulant

Liver fibrosis: Pathophysiology and clinical implications

2020 ◽  
pp. e1499
Author(s):  
Jennifer Berumen ◽  
Jacopo Baglieri ◽  
Tatiana Kisseleva ◽  
Kristin Mekeel
Keyword(s):  
Liver Fibrosis ◽  
Clinical Implications

Clinical implications on HBV preS/S mutations and the effects of preS2 deletion on mitochondria, liver fibrosis, and cancer development

Hepatology ◽  
2021 ◽  
Author(s):  
Yuh‐Jin Liang ◽  
Wei Teng ◽  
Chih‐Li Chen ◽  
Cheng‐Pu Sun ◽  
Rui‐Dung Teng ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Cancer Development ◽  
Clinical Implications

scholarly journals Use of Non-Invasive Parameters of Non-Alcoholic Steatohepatitis and Liver Fibrosis in Daily Practice - An Exploratory Case-Control Study

PLoS ONE ◽  
2014 ◽  
Vol 9 (10) ◽  
pp. e111551 ◽  
Author(s):  
Karel Dvorak ◽  
Jan Stritesky ◽  
Jaromir Petrtyl ◽  
Libor Vitek ◽  
Renata Sroubkova ◽  
...  
Keyword(s):  
Liver Fibrosis ◽  
Case Control Study ◽  
Daily Practice ◽  
Case Control ◽  
Non Invasive ◽  
Alcoholic Steatohepatitis ◽  
Control Study

scholarly journals Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254939
Author(s):  
Philippe Halfon ◽  
Christelle Ansaldi ◽  
Guillaume Penaranda ◽  
Laurent Chiche ◽  
Patrick Dukan ◽  
...  
Keyword(s):  
Primary Care ◽  
Liver Fibrosis ◽  
Daily Practice ◽  
Blood Analysis ◽  
Public Health Issue ◽  
Advanced Fibrosis ◽  
Systematic Calculation ◽  
Primary Care Population ◽  
Non Invasive ◽  
Routine Blood

Background & aim Liver fibrosis screening in primary care population is a major public health issue. The FIB-4 index is a simple non-invasive fibrosis test combining age, transaminases, platelets count, developed for the diagnosis of advanced fibrosis. The aim of our study was to evaluate the interest of liver fibrosis screening using systematic calculation of FIB-4 in routine blood analysis. Methods Between December 2018 and May 2019, we conducted a prospective screening of liver fibrosis in 134 158 patients during a medical check-up including routine blood analysis. Among these patients, 29 707 had transaminases and platelets counts available and benefited from an automatic calculation of FIB-4. Results were obtained from 21 French clinical laboratories in the Bouches du Rhône region. Results Among the 29 707 patients, 2161 (7.3%) had a high risk of advanced fibrosis (FIB-4>2.67). Individual investigation of patients with FIB-4>2.67 allowed to screen 1268 (1268/2161: 58.7%) patients who were not managed for any liver disease. Conclusions This work demonstrates the interest of FIB-4 for the screening of liver fibrosis in primary care population. Although additional clinical validation study is required to determine the utility and applicability of Fib-4 to daily practice, our study strongly supports this easy-to-implement strategy using a simple Fib-4 measure resulting from the use of available routine test results.

scholarly journals Strain Elastography (SE) for liver fibrosis estimation – which elastic score to calculate?

2016 ◽  
Vol 18 (4) ◽  
pp. 481 ◽  
Author(s):  
Mariana M. Gersak ◽  
Monica Lupșor-Platon ◽  
Radu Badea ◽  
Anca Ciurea ◽  
Sorin M Dudea
Keyword(s):  
Liver Fibrosis ◽  
Liver Biopsy ◽  
Quantitative Method ◽  
Estimation Method ◽  
Daily Practice ◽  
Ultrasound Elastography ◽  
Fibrosis Score ◽  
Strain Elastography ◽  
Non Invasive ◽  
Similar Accuracy

Liver fibrosis scoring by liver biopsy has become a rarity in daily practice mainly because many non-invasive methods with similar accuracy have been developed. Among all ultrasound elastography imaging methods, Strain Elastography (SE) is the most widely available. Although SE is a qualitative and semi-quantitative method, there is reliable applicability for liver fibrosis estimation and multiple ways to transform SE into a quantitative method, in order to obtain a fibrosis score. The aim of this review is to briefly introduce all these methods and to offer support in choosing the best estimation method for liver fibrosis, with SE.

scholarly journals Incidence of Extrahepatic Portal Vein Anatomic Variations and Their Clinical Implications in Daily Practice

2021 ◽  
Vol 13 (9) ◽  
pp. 460-465
Author(s):  
Anastasios Katsourakis ◽  
Dimitrios Chytas ◽  
Eva Filo ◽  
Iosif Chatzis ◽  
Pantelis Chouridis ◽  
...  
Keyword(s):  
Portal Vein ◽  
Daily Practice ◽  
Clinical Implications ◽  
Anatomic Variations
Sign in / Sign up

Export Citation Format

Share Document